{"a":[{"_":"Curium strikes up to $8B deal for radiopharma rival Lantheus","$":{"href":"/medtech/curium-strikes-8b-deal-radiopharma-rival-lantheus","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Curium has agreed to acquire Lantheus in an all-cash deal valued at up to $8 billion, combining two leading radiopharma companies. The transaction follows months of speculation about a potential takeover.
Importance:8/10
Sentiment:
0.70
M&Aradiopharmaacquisition
Related Companies
Read the original article
Published by FiercePharma on August 3, 2026 1:56 PM
